Latest Share Chat

REMOVE ADS

Faron Pharmaceuticals Share News (FARN)

Faron Pharmaceuticals Information

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes

Get Live Data

46.00 0.00 (0.00%)

Bid:

45.00

Ask:

47.00

Spread: 2.00 (4.444%)

Market Cap: £91.78m

Last checked at -

Intraday Faron Pharmaceuticals Share Chart

REMOVE ADS

Faron Pharmaceuticals News

UK earnings, trading statements calendar - next 7 days

UK shareholder meetings calendar - next 7 days

IN BRIEF: Faron raises EUR5 million for bexmarilimab development

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Conducts private placing to raise EUR5 million in 2.0 mill...

IN BRIEF: Faron Pharma reveals topline results from MATINS trial

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Announces top-line overall survival results from its phase...

IN BRIEF: Faron Pharma doses first patient in bexmarilimab study

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Doses first patient in the phase I/II BEXMAB study. The st...

IN BRIEF: US and Finland approve Faron's bexmarilimab study

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - US Food & Drug Administration and Finnish Medicines Agency...

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

IN BRIEF: Faron Pharmaceuticals CEO buys shares worth EUR71,000

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Chief Executive Markku Jalkanen buys 25,000 shares at an a...